• About
  • Subscribe
  • Advertise
  • Contact
Friday, January 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

AMA ‘strongly opposed’ to drug-prescribing changes

by Rob Mitchell
January 9, 2026
in Local, News, Ophthalmic insights, Ophthalmic Treatments, Optometrists, Optometry, Pharmaceuticals & consumables, Policy & regulation
Reading Time: 3 mins read
A A
The proposal to change what drugs optometrists can prescribe has met with a strong response. Image: bukhta79/stock.adobe.com.

The proposal to change what drugs optometrists can prescribe has met with a strong response. Image: bukhta79/stock.adobe.com.

Share on FacebookShare on Twitter

Proposals to expand the drugs that optometrists can administer have sparked new opposition but also some support.

The Australian Medical Association (AMA) has strongly opposed plans by the Optometry Board of Australia to expand optometrist prescribing rights to include oral medicines, warning the move poses unacceptable risks to patient safety.

But the Pharmacy Guild of Australia has thrown its weight behind the change, saying it is another “positive step toward improving patient access to timely, affordable, and effective care”.

In a media release, the AMA said its submission to the board’s consultation on the proposal highlighted that optometrists lacked “the extensive medical training required to safely manage the systemic risks associated with oral medicines”.

AMA vice president Associate Professor Julian Rait said using workforce shortages to justify expanding non-medical prescribing was reckless and put patients at risk.

“Patient safety must come first and the board needs to recognise that inappropriate prescribing of these medicines can have very significant consequences for patients,” A/Prof Rait said.

“Unlike medical practitioners, optometrists simply don’t have the comprehensive training needed to provide holistic diagnoses and manage the complex systemic risks that come with prescribing oral medicines.”

The AMA said evidence cited in the board’s own consultation documents revealed concerning gaps in optometry training.

It said the Optometry Council of Australia and New Zealand report found that the reviewed optometry programs did not equip optometrists with sufficient knowledge to understand the types, causes, and risks of medicine errors.

A/Prof Rait warned the proposed changes risked fragmenting patient care and creating confusion about who was responsible for a patient’s overall medication regime.

“Expanding prescribing rights without robust evidence and safeguards undermines the integrity of Australia’s healthcare system.

“We need a clear distinction between medical and non-medical roles to ensure prescribing remains the responsibility of those with appropriate training and accountability.

“The AMA believes optometrists should not be permitted to prescribe beyond topical agents under current arrangements,” he said.

However, the Pharmacy Guild of Australia has welcomed the proposal.

National president Professor Trent Twomey said the proposal reflected a growing recognition that empowering qualified health professionals to practise to the full extent of their training delivered better outcomes for patients and communities — particularly in rural and regional Australia.

“When patients can access the right care from the right health professional at the right time, everyone benefits,” Prof Twomey said.

“This proposal aligns with the guild’s long-held view that scope of practice reforms across health professions — including community pharmacy — are essential to strengthening Australia’s primary care system.”

The guild noted the proposed changes would allow optometrists to prescribe oral medicines where clinically appropriate, reducing unnecessary delays and helping patients avoid preventable complications, such as vision loss.

Prof Twomey said this collaborative, multi-professional approach to healthcare reflected the intent of the National Medicines Policy and National Strategy for Quality Use of Medicines — both of which emphasise safe, effective, and accessible use of medicines.

“Optometrists, pharmacists, nurses, and other health professionals all play vital roles in delivering care closer to home.

“By supporting initiatives like this, governments can continue to build a more integrated and patient-centred health system. The outcome ultimately will be healthier Australian communities,” he said.

 

Related Posts

optometrists cyber-crimes

Smart glasses market tipped to hit $200b by 2040

by Rob Mitchell
January 16, 2026

Financial analysts are predicting rapid growth of the smart glasses market, with one global eyewear giant predicted to potentially double...

Sophi is an eco-conscious phaco system. Image: Rayner.

FDA clears Rayner’s Sophi device for US market

by Staff Writer
January 15, 2026

British ophthalmic equipment manufacturer Rayner has secured US Food and Drug Administration (FDA) clearance for Sophi, its Swiss-engineered phacoemulsification system....

Previous winner of the ODA National Medal for Optical Dispensing Excellence, Dominique Jorgensen (right), with ODA chief executive April Petrusma, and Todd Spencer of CR Labs. Image: Insight

Nominations open for 2026 ODA National Excellence Awards

by Staff Writer
January 15, 2026

Optical Dispensers Australia (ODA) has opened nominations for the 2026 ODA National Excellence Awards, offering what it calls a unique...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited